Ex Parte BUECHLER et al - Page 4


                     Appeal No.  2002-0019                                                                           Page 4                       
                     Application No.  08/517,949                                                                                                  

                     Buechler II and Buechler III to make up for the deficiency in Collins.  According                                            
                     to the examiner each of the Buechler patents                                                                                 
                              teach raising antibodies to drug derivatives comprising the same                                                    
                              sulfur-containing linkers as instantly claimed and, consequently, it                                                
                              would have been obvious to derivatize a TCA as taught by Collins                                                    
                              … at the secondary amine as taught by Collins and to attach the                                                     
                              sulfur-containing linkers of [any one of the] Buechler patents … at                                                 
                              the secondary amine of the TCA molecule because Collins                                                             
                              demonstrates successful derivatization of TCAs at that location and                                                 
                              because one would have been motivated to use the linkers                                                            
                              disclosed in the three Buechler patents because, in each of the                                                     
                              Buechler patents, drug derivatives using those linkers were                                                         
                              successfully used to raise antibodies for use in drug                                                               
                              immunoassays.                                                                                                       
                              As set forth in In re Kotzab, 217 F.3d 1365, 1369-70, 55 USPQ2d 1313,                                               
                     1316 (Fed. Cir. 2000):                                                                                                       
                              A critical step in analyzing the patentability of claims pursuant to                                                
                              section 103(a) is casting the mind back to the time of invention, to                                                
                              consider the thinking of one of ordinary skill in the art, guided only                                              
                              by the prior art references and the then-accepted wisdom in the                                                     
                              field. … Close adherence to this methodology is especially                                                          
                              important in cases where the very ease with which the invention                                                     
                              can be understood may prompt one “to fall victim to the insidious                                                   
                              effect of a hindsight syndrome wherein that which only the                                                          
                              invention taught is used against its teacher.” …                                                                    
                              Most if not all inventions arise from a combination of old elements.                                                
                              … Thus, every element of a claimed invention may often be found                                                     
                              in the prior art. … However, identification in the prior art of each                                                
                              individual part claimed is insufficient to defeat patentability of the                                              
                              whole claimed invention. … Rather, to establish obviousness based                                                   
                              on a combination of the elements disclosed in the prior art, there                                                  
                              must be some motivation, suggestion or teaching of the desirability                                                 
                              of making the specific combination that was made by the applicant.                                                  
                              [citations omitted]                                                                                                 
                     In other words, “there still must be evidence that ‘a skilled artisan, . . . with no                                         
                     knowledge of the claimed invention, would select the elements from the cited                                                 
                     prior art references for combination in the manner claimed.’”  Ecolochem Inc. v.                                             





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007